Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,otherCashflowsFromInvestingActivities,otherCashflowsFromFinancingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingPE,gmtOffSetMilliseconds,esgPopulated,tradeable,currency,marketState,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,shortName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchangeDataDelayedBy,exchange,priceHint,market,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Jun 14, 2021) 4","Short Ratio (Jun 14, 2021) 4","Short % of Float (Jun 14, 2021) 4","Short % of Shares Outstanding (Jun 14, 2021) 4","Shares Short (prior month May 13, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,fax,industry
t0,IART,-674422000.0,84549296,16859000,,67278000,,45394000,145139000,224427000,57902000,57902000,,-12929000,,,,21884000,360071000,302169000,135644000,9376000,,45394000,45394000,1193681000.0,1231637000.0,2212223000.0,1529331000.0,23465000.0,3741554000.0,894000.0,15292000.0,574888000.0,172744000.0,1010072000.0,-278088000.0,96852000.0,408976000.0,412301000.0,74626000.0,177237000.0,-43627000.0,387367000.0,1039075000.0,14507000.0,230041000.0,1531629000.0,328049000.0,61500000.0,14366000.0,-117566000.0,-1600000.0,-3015000.0,-2817000.0,2222000.0,-61190000.0,-3637000.0,-9690000.0,69081000.0,29214000.0,-2332000.0,16756000.0,-33221000.0,-6675000.0,,,626774000.0,en-US,US,EQUITY,True,Delayed Quote,1.0368187,74.7 - 76.07,75.23,0.0,0.0,11,9,finmb_30012,NasdaqGS,Integra LifeSciences Holdings Corporation,USD,366350,380857,33.890003,0.80460596,42.12 - 77.4,-1.3899994,-0.017958649,42.12,77.4,1619589600,1635251400,1635769800,38.138485,-14400000,False,False,USD,PRE,1.993,3.36,3.02,25.168875,18.097,70.47143,5.538574,0.07859319,69.909134,6.100868,0.087268546,6426592256,22.622025,4.200144,15,America/New_York,EDT,Integra LifeSciences Holdings C,76.01,1630526403,0.7799988,75.38,76.07,74.7,395589,0,NMS,2,us_market,1.23,,,77.4,42.12,70.47,69.91,366.35k,380.86k,84.55M,,72.75M,14.07%,89.83%,4.03M,11.61,6.46%,4.77%,4.05M,,,,,,0.00%,,,2:1,"Jan 03, 2017","Dec 30, 2020","Mar 30, 2021",12.35%,16.78%,4.02%,11.85%,1.38B,16.31,1.60%,885.59M,347.22M,170.11M,1.99,394.50%,408.98M,4.84,1.82B,118.90,2.52,18.10,252.1M,242.68M,Value,08540,Healthcare,3700,3,6,"Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, bone and joint fixation implants in the upper and lower extremities, and bone grafts products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.",Princeton,609 275 0500,NJ,1,1609372800,1622505600,2,United States,http://www.integralife.com,86400,1,1100 Campus Road,609 750 4277,Medical Devices
t-1,IART,-406936000.0,84549296,18452000,,38916000,,92744000,150262000,253635000,80557000,80557000,,-17351000,,,,-53828000,388647000,308090000,135012000,-41641000,,92744000,92744000,989436000.0,1290909000.0,2100269000.0,1514867000.0,26645000.0,3615136000.0,893000.0,175025000.0,532265000.0,131181000.0,932367000.0,-309200000.0,84967000.0,470166000.0,401013000.0,73690000.0,168283000.0,-74059000.0,371164000.0,1237202000.0,,234212000.0,1479957000.0,310117000.0,54608000.0,10177000.0,-35921000.0,20200000.0,21222000.0,7892000.0,1411000.0,73887000.0,-389000.0,8324000.0,80262000.0,26178000.0,-2817000.0,-5758000.0,-54071000.0,-8427000.0,-7840000.0,,836189000.0,en-US,US,EQUITY,True,Delayed Quote,1.0368187,74.7 - 76.07,75.23,0.0,0.0,11,9,finmb_30012,NasdaqGS,Integra LifeSciences Holdings Corporation,USD,366350,380857,33.890003,0.80460596,42.12 - 77.4,-1.3899994,-0.017958649,42.12,77.4,1619589600,1635251400,1635769800,38.138485,-14400000,False,False,USD,PRE,1.993,3.36,3.02,25.168875,18.097,70.47143,5.538574,0.07859319,69.909134,6.100868,0.087268546,6426592256,22.622025,4.200144,15,America/New_York,EDT,Integra LifeSciences Holdings C,76.01,1630526403,0.7799988,75.38,76.07,74.7,395589,0,NMS,2,us_market,1.23,,,77.4,42.12,70.47,69.91,366.35k,380.86k,84.55M,,72.75M,14.07%,89.83%,4.03M,11.61,6.46%,4.77%,4.05M,,,,,,0.00%,,,2:1,"Jan 03, 2017","Dec 30, 2020","Mar 30, 2021",12.35%,16.78%,4.02%,11.85%,1.38B,16.31,1.60%,885.59M,347.22M,170.11M,1.99,394.50%,408.98M,4.84,1.82B,118.90,2.52,18.10,252.1M,242.68M,Value,08540,Healthcare,3700,3,6,"Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, bone and joint fixation implants in the upper and lower extremities, and bone grafts products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.",Princeton,609 275 0500,NJ,1,1609372800,1622505600,2,United States,http://www.integralife.com,86400,1,1100 Campus Road,609 750 4277,Medical Devices
t-2,IART,-495254000.0,84549296,18601000,,41511000,,32337000,143930000,242313000,71439000,71439000,,-20796000,,,,9174000,370232000,298793000,127919000,-29928000,,32337000,32337000,973685000.0,1284711000.0,2055534000.0,1397987000.0,23689000.0,3453521000.0,892000.0,174002000.0,439521000.0,127254000.0,919556000.0,-327137000.0,28829000.0,396279000.0,255146000.0,8150000.0,44824000.0,-91913000.0,379355000.0,1152096000.0,,224837000.0,1584356000.0,307839000.0,50254000.0,21582000.0,-6718000.0,-28900000.0,-33049000.0,-343000.0,223000.0,35298000.0,-289000.0,5426000.0,69639000.0,31027000.0,1510000.0,-37430000.0,11713000.0,-6727000.0,-7840000.0,-4083000.0,896950000.0,en-US,US,EQUITY,True,Delayed Quote,1.0368187,74.7 - 76.07,75.23,0.0,0.0,11,9,finmb_30012,NasdaqGS,Integra LifeSciences Holdings Corporation,USD,366350,380857,33.890003,0.80460596,42.12 - 77.4,-1.3899994,-0.017958649,42.12,77.4,1619589600,1635251400,1635769800,38.138485,-14400000,False,False,USD,PRE,1.993,3.36,3.02,25.168875,18.097,70.47143,5.538574,0.07859319,69.909134,6.100868,0.087268546,6426592256,22.622025,4.200144,15,America/New_York,EDT,Integra LifeSciences Holdings C,76.01,1630526403,0.7799988,75.38,76.07,74.7,395589,0,NMS,2,us_market,1.23,,,77.4,42.12,70.47,69.91,366.35k,380.86k,84.55M,,72.75M,14.07%,89.83%,4.03M,11.61,6.46%,4.77%,4.05M,,,,,,0.00%,,,2:1,"Jan 03, 2017","Dec 30, 2020","Mar 30, 2021",12.35%,16.78%,4.02%,11.85%,1.38B,16.31,1.60%,885.59M,347.22M,170.11M,1.99,394.50%,408.98M,4.84,1.82B,118.90,2.52,18.10,252.1M,242.68M,Value,08540,Healthcare,3700,3,6,"Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, bone and joint fixation implants in the upper and lower extremities, and bone grafts products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.",Princeton,609 275 0500,NJ,1,1609372800,1622505600,2,United States,http://www.integralife.com,86400,1,1100 Campus Road,609 750 4277,Medical Devices
t-3,IART,-605797000.0,84549296,14302000,,1651000,,-369000,114844000,159487000,22268000,22268000,,-15682000,,,,2020000,258665000,236397000,99178000,-20617000,,-369000,-369000,998686000.0,1279370000.0,2042663000.0,1349096000.0,10107000.0,3391759000.0,892000.0,14725000.0,407184000.0,110968000.0,956207000.0,-338350000.0,42930000.0,360981000.0,212415000.0,7529000.0,33951000.0,-103124000.0,427714000.0,966222000.0,,186545000.0,1620449000.0,358756000.0,58291000.0,-49411000.0,-3949000.0,-29800000.0,-28553000.0,-470000.0,1295000.0,3269000.0,-49000.0,2654000.0,33117000.0,29675000.0,-20805000.0,66992000.0,1949000.0,-7217000.0,-7840000.0,1000.0,753807000.0,en-US,US,EQUITY,True,Delayed Quote,1.0368187,74.7 - 76.07,75.23,0.0,0.0,11,9,finmb_30012,NasdaqGS,Integra LifeSciences Holdings Corporation,USD,366350,380857,33.890003,0.80460596,42.12 - 77.4,-1.3899994,-0.017958649,42.12,77.4,1619589600,1635251400,1635769800,38.138485,-14400000,False,False,USD,PRE,1.993,3.36,3.02,25.168875,18.097,70.47143,5.538574,0.07859319,69.909134,6.100868,0.087268546,6426592256,22.622025,4.200144,15,America/New_York,EDT,Integra LifeSciences Holdings C,76.01,1630526403,0.7799988,75.38,76.07,74.7,395589,0,NMS,2,us_market,1.23,,,77.4,42.12,70.47,69.91,366.35k,380.86k,84.55M,,72.75M,14.07%,89.83%,4.03M,11.61,6.46%,4.77%,4.05M,,,,,,0.00%,,,2:1,"Jan 03, 2017","Dec 30, 2020","Mar 30, 2021",12.35%,16.78%,4.02%,11.85%,1.38B,16.31,1.60%,885.59M,347.22M,170.11M,1.99,394.50%,408.98M,4.84,1.82B,118.90,2.52,18.10,252.1M,242.68M,Value,08540,Healthcare,3700,3,6,"Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, bone and joint fixation implants in the upper and lower extremities, and bone grafts products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.",Princeton,609 275 0500,NJ,1,1609372800,1622505600,2,United States,http://www.integralife.com,86400,1,1100 Campus Road,609 750 4277,Medical Devices
